How Analysts Rated Vical Incorporated (NASDAQ:VICL) Last Week?

October 13, 2017 - By Nellie Frank

 How Analysts Rated Vical Incorporated (NASDAQ:VICL) Last Week?

Vical Incorporated (NASDAQ:VICL) Ratings Coverage

Among 2 analysts covering Vical (NASDAQ:VICL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vical had 4 analyst reports since July 19, 2016 according to SRatingsIntel. The stock of Vical Incorporated (NASDAQ:VICL) earned “Buy” rating by H.C. Wainwright on Wednesday, August 9. The company was reinitiated on Tuesday, July 19 by H.C. Wainwright. Rodman \u0026 Renshaw reinitiated the stock with “Buy” rating in Monday, June 12 report. The firm earned “Buy” rating on Monday, June 12 by H.C. Wainwright. Below is a list of Vical Incorporated (NASDAQ:VICL) latest ratings and price target changes.

09/08/2017 Broker: H.C. Wainwright Rating: Buy New Target: $9.0000 Maintain
12/06/2017 Broker: H.C. Wainwright Rating: Buy New Target: $9.0000 Maintain
12/06/2017 Broker: Rodman \u0026 Renshaw Rating: Buy New Target: $9 Reinitiate

About 112,809 shares traded. Vical Incorporated (NASDAQ:VICL) has declined 38.65% since October 13, 2016 and is downtrending. It has underperformed by 55.35% the S&P500.

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid delivery technologies for the prevention and treatment of life-threatening diseases. The company has market cap of $32.15 million.

More important recent Vical Incorporated (NASDAQ:VICL) news were published by: which released: “Vical Announces that its Antifungal VL-2397 is Eligible for Limited Use …” on October 02, 2017, also published article titled: “Vical Announces Completion of the Phase 3 ASP0113 CMV Vaccine Trial”, published: “18 Stocks Moving In Tuesday’s Pre-Market Session” on October 03, 2017. More interesting news about Vical Incorporated (NASDAQ:VICL) was released by: and their article: “Vical to Present at IDWeek and the 8th Trends in Medical Mycology Conferences” with publication date: September 28, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.